Explore evidence

1.8 RRModerate-to-severe food insecurity was associated with a relative risk of 1.80 for virologic non-suppression.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 6 observations

91 %Retention at six months among the control group was 91%.

KenyaVIH/sidapublished 2022International journal of environmental research and public healthPubMeddocument of 5 observations

35.7 %35.7% of participants in the intervention arm on antiretroviral therapy had detectable viral loads.

KenyaVIH/sidapublished 2025AIDS (London, England)PubMeddocument of 6 observations

Incidence of HIV acquisition over 3 years was measured in mobile and non-mobile adults in 32 rural communities in three regions of Uganda and Kenya participating in the SEARCH trial from 2013 to 2017.

Kenya · OugandaVIH/sidaobserved 2013-2017published 2025AIDS and behavioreurope_pmcdocument of 18 observations

621,115 patientsThe study used data from 621,115 patients who started antiretroviral therapy (ART) between 2017 and 2023 in Kenya.

KenyaVIH/sidaobserved 2017–2023published 2026JMIR medical informaticsPubMeddocument of 5 observations

38 %38% (60) of partners in the invitation strategy tested for HIV.

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations

88 %Among 1011 adolescents and youth with HIV (AYWHIV) ages 15–24 years in Western Kenya, 88% reported disclosure concerns.

KenyaVIH/sidapublished 2023AIDS and behaviorPubMeddocument of 11 observations

1.09 adjusted_risk_ratioCompared to the pre-COVID-19 period, the COVID-19 period had higher same-day HIV diagnosis/ART initiation with an adjusted risk ratio of 1.09 (95% CI: 1.04–1.13).

KenyaVIH/sidaobserved April 2020–March 2021 vs. pre-COVID-19published 2023PloS onePubMeddocument of 7 observations

17.5 %HIV prevalence among female sex workers less than 25 years of age in Nairobi was 17.5% in 2008–2009.

KenyaVIH/sidaobserved 2008–2009published 2021AIDS (London, England)PubMeddocument of 13 observations

0.2 log_copies_per_mLBland-Altman analysis showed a systematic bias of less than 0.20 log copies/mL between viral load in Abbott RealTime HIV-1 Assay plasma and various sample types tested in Hologic Aptima HIV-1 Quant Dx Assay.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 3 observations

11 %All-cause mortality during TB treatment was 11% among men and 9% among women among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

28.4 %Among 7,046 individuals sampled starting antiretroviral therapy (ART) in Kenya between April 2018 and March 2021, 28.4% started ART during April 2020–March 2021.

KenyaVIH/sidaobserved April 2020–March 2021published 2023PloS onePubMeddocument of 7 observations

0 casesNone of the 58 male relatives tested HIV-positive.

KenyaVIH/sidapublished 2023BMC public healthPubMeddocument of 15 observations

51 %PLHIV had a 51% higher mean IL-6 concentration compared with HIV-negative participants, independent of CVD risk factors.

KenyaVIH/sidapublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 8 observations

8.6 %In Nairobi, Kenya, 8.6% of 532 HIV-positive women and men were classified as having recent HIV infection.

KenyaVIH/sidaobserved 2018published 2020Journal of the International AIDS SocietyPubMeddocument of 4 observations

16 %Overall HIV prevalence among 11,899 female sex workers in Nairobi was 16%.

KenyaVIH/sidaobserved 2014 to 2017published 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

35.4 %Aflatoxin B1 was detected in 17 of 48 women living with HIV with undetectable HIV viral load (35.4%).

KenyaVIH/sidapublished 2025International journal of STD & AIDSPubMeddocument of 8 observations

1,066 youthOf 1066 youth with HIV enrolled between November 1, 2019, and March 18, 2020, 578 (54%) were in intervention sites and 488 (46%) were in control sites.

KenyaVIH/sidaobserved November 1, 2019 to March 18, 2020published 2022The lancet. HIVPubMed

0.22 odds_ratioAfter adjustment for time on ART, there was no difference in the detection of cervical HIV-1 RNA before versus during GUD (adjusted OR 0.22, 95% CI 0.04 to 1.23).

Kenyagenital ulcer disease (GUD) · VIH/sidapublished 2011Sexually transmitted infectionseurope_pmcdocument of 4 observationsDOI 10.1136/sti.2010.045369

11 casesOver the course of the study, 11 orphaned children acquired HIV.

KenyaVIH/sidapublished 2023The Journal of pediatricsPubMeddocument of 7 observations

1.08 daysThe mean time from sample collection to maternal notification was 1.08 days.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 13 observations

82.4 %Affordability was cited as a dimension of water insecurity by 82.4% of participants.

KenyaVIH/sidapublished 2026Journal of water and healtheurope_pmcdocument of 11 observations

2.5 %Machine error rates for point-of-care HIV testing were 2.5% at 6 weeks.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 13 observations

60 %Among those in a stable relationship, 79 (60%) reported that their partner was living with HIV.

KenyaVIH/sidapublished 2023BMC public healthPubMeddocument of 8 observations

102 casesAmong the 'test and treat' group, 102 (32%) people living with HIV had poor outcomes.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 15 observations